Deutsche Bank analyst Brian Bedell raised its price target on CME Group Inc. (NASDAQ:CME) to $218 from $200 and maintained a buy rating on the stock. The analyst told investors that the company’s fourth-quarter results were “fairly solid,” with modest growth in revenue and interest income and a sharper increase in adjusted expenses. However, CME Group is demonstrating pricing power by increasing futures/options RPCs this year, which is actually a 4%-5% revenue increase. Combined with organic growth plans and transaction volume growth at a low median rate, Deutsche Bank believes the company’s EPS growth rate this year will be closer to 10 percent, up from just 3 percent previously.